Key result
AI and digital tools can optimize CV screening and tailored prevention across a woman's lifespan.
Why the study?
Cardiovascular disease remains the leading cause of death in women, but healthcare providers and policy experts are not yet sufficiently equipped to optimize, interpret, or leverage data to target preventive screening and interventions across a woman's life span.
This review highlights the potential of artificial intelligence and digital tools to improve cardiovascular disease screening and tailored preventive interventions in women.
No takes yet. Share an insight, caveat, or question.
May enable tailored CVD prevention in women; leaves open prospective validation before clinical adoption.
A 2022 study conducted a review in Cardiovascular disease. Artificial intelligence and digital tools was evaluated. Artificial intelligence and digital technologies offer key opportunities to optimize cardiovascular disease screening and tailored preventive interventions across a woman's life span.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: